Jane Street
RCUS icon

Jane Street’s Arcus Biosciences RCUS Stock Holding History

Jane Street’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Sell
68,300
-6,600
-9% -$143K ﹤0.01% 5681
2025
Q4 		$1.78M Sell
74,900
-19,000
-20% -$388K ﹤0.01% 5026
2025
Q3 		$1.28M Buy
93,900
+10,400
+12% +$108K ﹤0.01% 5803
2025
Q2 		$680K Buy
+83,500
New +$713K ﹤0.01% 6361
2024
Q2 		– Sell
-17,100
Closed -$323K – 10048
2024
Q1 		$323K Sell
17,100
-23,400
-58% -$405K ﹤0.01% 7442
2023
Q4 		$774K Sell
40,500
-113,800
-74% -$1.82M ﹤0.01% 6031
2023
Q3 		$2.77M Buy
+154,300
New +$3.1M ﹤0.01% 3497
2023
Q2 		– Sell
-30,100
Closed -$549K – 9428
2023
Q1 		$549K Buy
+30,100
New +$575K ﹤0.01% 6177
2022
Q4 		– Sell
-31,100
Closed -$814K – 9962
2022
Q3 		$814K Buy
31,100
+20,100
+183% +$532K ﹤0.01% 5807
2022
Q2 		$279K Buy
+11,000
New +$269K ﹤0.01% 7729
2020
Q4 		– Sell
-16,400
Closed -$281K – 7999
2020
Q3 		$281K Sell
16,400
-2,300
-12% -$51.4K ﹤0.01% 5970
2020
Q2 		$463K Buy
+18,700
New +$505K ﹤0.01% 5195

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jane Street's RCUS Position: Q1 2026 in Review

Jane Street increased its Arcus Biosciences (RCUS) stake by 132% in Q1 2026, buying an estimated $1.33M and bringing the position to 107,979 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #4794.

Jane Street first reported a position in RCUS in Q4 2018 and has held it in 23 quarters since. The position peaked at $6.33M in Q4 2023. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Jane Street held 107,979 shares of Arcus Biosciences worth $2.33M as of Q1 2026.
  • Jane Street bought 61,474 Arcus Biosciences shares in Q1 2026, an estimated $1.33M.
  • Arcus Biosciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4794 holding.
  • Jane Street first reported a position in Arcus Biosciences in Q4 2018 and has held it in 23 quarters since.
  • Jane Street's Arcus Biosciences position peaked at $6.33M in Q4 2023.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.